Nosocomial infections related to the development of ... but some of them may be salved by combining systemic and antibiotic-lock treatment. After reviewing some specific therapeutic aspects ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Researchers at IISc have developed an enzyme treatment that dismantles biofilms formed by Klebsiella pneumoniae, enhancing the action of antibiotics. Tests on biofilms and infected mice showed ...

Conducted across six hospitals in China, the study assessed 335 CTD patients who had developed pneumonia while on ...

Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...

Health insurers use AI to deny certain claims and maximize their profits, a Senate report suggests. Hospitals around the ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into ...

Water Saver Solutions Inc., the innovator behind FixtureCare, is proud to honor UC Davis Health as the 2024 FixtureCare ...

Last Patient Enrolled for Planned Unblinded Interim Analysis in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 Unblinded Interim Analysis Outcome ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025 Reiterate cash runway into mid-2026; Q3 2024 ending cash balance of $76.3M CAMBRIDGE, Mass., Nov. 14 ...